| WHO-WIPO-WTO/IP/MED/GE/11/A0 | English | Summary and Key Issues |  |
| WHO-WIPO-WTO/IP/MED/GE/11/REF/A2/LAMY | English | Opening Remarks - Mr. Pascal Lamy | |
| WHO-WIPO-WTO/IP/MED/GE/11/REF/A/AVIDEOS | English | Videos |  |
| WHO-WIPO-WTO/IP/MED/GE/11/REF/A/CHAN | English | Opening Remarks - Mrs. Margaret Chan | |
| WHO-WIPO-WTO/IP/MED/GE/11/REF/B1/MIRZA | English | Access and Information Needs from a Public Health Perspective - Mr. Zafar Mirza | |
| WHO-WIPO-WTO/IP/MED/GE/11/REF/B2/TAUBMAN | English | Access to Medicines, Patent Information and Freedom to Operate - Mr. Anthony Taubman | |
| WHO-WIPO-WTO/IP/MED/GE/11/REF/B3/KRATTIGER | English | Managing IP for Access - Mr. Anatole Krattiger | |
| WHO-WIPO-WTO/IP/MED/GE/11/REF/B4/KOWALSKI | English | Patent Literature and Methodology: WHO Model List of Essential Medicines - Mr. Stan Kowalski | |
| WHO-WIPO-WTO/IP/MED/GE/11/REF/B5/LAING | English | The Patent Status of Medicines on the WHO Model List of Essential Medicines - Mr. Richard Laing | |
| WHO-WIPO-WTO/IP/MED/GE/11/REF/B6/THOEN | English | The Medicines Patent Pool - Understanding the Patent Status of Antiretroviral Drugs - Mrs. Ellen ‘t Hoen | |
| WHO-WIPO-WTO/IP/MED/GE/11/REF/B7/FRIEDE | English | Patent Landscaping for Vaccines: Patent Information, Tools and Methodologies - Mr. Martin Friede | |
| WHO-WIPO-WTO/IP/MED/GE/11/REF/B8/MAHONEY | English | IP and Dengue Vaccines: A case study - Mr. Richard T. Mahoney | |
| WHO-WIPO-WTO/IP/MED/GE/11/REFB9//LM | English | WIPO's Legal Status Data Project - Mr. Lutz Mailänder | |
| WHO-WIPO-WTO/IP/MED/GE/11/REF/B10/LOGEZ | English | Global Fund Experience: Access to Patent Information and Impact on Procurement of Medicines - Ms. Sophie Logez | |
| WHO-WIPO-WTO/IP/MED/GE/11/REF/B11/TAMIN | English | Searching for Transparency: Patent Information in Practice - Mr. Tahir Amin | |
| WHO-WIPO-WTO/IP/MED/GE/11/REF/A1/GURRY | English | Opening Remarks - Mr. Francis Gurry | |
